Related references
Note: Only part of the references are listed.3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Personalizing IBD Therapy: The Asian Perspective
Suk-Kyun Yang
DIGESTIVE DISEASES (2016)
Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn's Disease: A Hospital-Based Cohort Study
Sang Hyoung Park et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Changing epidemiological trends of inflammatory bowel disease in Asia
Wee Khoon Ng et al.
INTESTINAL RESEARCH (2016)
Effectiveness and Safety of lmmunomodulators With Anti-Tumor Necrosis Factor Therapy in Crohn's Disease
Mark T. Osterman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
Reena Khanna et al.
LANCET (2015)
Crohn's disease management after intestinal resection: a randomised trial
Peter De Cruz et al.
LANCET (2015)
Early Thiopurines Versus Conventional Step-Care Therapy for Modifying the Disease Course of Early Crohn's Disease
Yun Qiu et al.
MEDICINE (2015)
Treatment algorithms in Crohn's - Up, down or something else?
Ophelie Antunes et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Adalimumab Induces Deep Remission in Patients With Crohn's Disease
Jean-Frederic Colombel et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Remo Panaccione et al.
GASTROENTEROLOGY (2014)
Long-term Prognosis of Crohn's Disease and Its Temporal Change Between 1981 and 2012: A Hospital-based Cohort Study from Korea
Sang Hyoung Park et al.
INFLAMMATORY BOWEL DISEASES (2014)
How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort
Claudia Ott et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases
William J. Sandborn et al.
JOURNAL OF CROHNS & COLITIS (2014)
Top-Down or Step-Up Treatment in Crohn's Disease?
Gerhard Rogler
DIGESTIVE DISEASES (2013)
Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
Jacques Cosnes et al.
GASTROENTEROLOGY (2013)
Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
Julian Panes et al.
GASTROENTEROLOGY (2013)
Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977-2009
Peter Laszlo Lakatos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial
Paul Rutgeerts et al.
GASTROENTEROLOGY (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Response to biologic therapy in Crohn's disease is improved with early treatment: An analysis of health claims data
David T. Rubin et al.
INFLAMMATORY BOWEL DISEASES (2012)
Predictive factors for an uncomplicated long-term course of Crohn's disease: A retrospective analysis
W. Kruis et al.
Journal of Crohns & Colitis (2012)
Review article: infliximab for Crohn's disease treatment - shifting therapeutic strategies after 10 years of clinical experience
S. Danese et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change
Ingrid Ordas et al.
GUT (2011)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease
M. J. L. Romberg-Camps et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease
Peter Laszlo Lakatos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: A KASID study
Suk-Kyun Yang et al.
INFLAMMATORY BOWEL DISEASES (2008)
Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease:: an open randomised trial
Geert D'Haens et al.
LANCET (2008)
Predictors of severe Crohn's disease
Catherine Loly et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Clinical course in Crohn's disease: Results of a Norwegian population-based ten-year follow-up study
Inger Camilla Solberg et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Certolizumab pegol for the treatment of Crohn's disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Maintenance therapy with certolizumab pegol for Crohn's disease
Stefan Schreiber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Factors associated with the development of intestinal strictures or obstructions in patients with .Crohn's disease
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
GR Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Predictors of Crohn's disease
L Beaugerie et al.
GASTROENTEROLOGY (2006)
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Long-term evolution of disease behavior of Crohn's disease
J Cosnes et al.
INFLAMMATORY BOWEL DISEASES (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Share Paper
